TELO · Insider Trading
Telomir Pharmaceuticals, Inc. Common Stock
Every open-market purchase and sale reported by TELO officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-27 | Edward Clouston MacPherson | Director | A | +50,000 deriv. | — |
| 2026-07-27 | Matthew Paul Del Giudice | Director | A | +50,000 deriv. | — |
| 2026-07-27 | Matthew Pratt Whalen | Director | A | +50,000 deriv. | — |
| 2026-05-22 | Matthew Paul Del Giudice | Director | MIXED | — | — |
| 2026-05-22 | Matthew Pratt Whalen | Director | MIXED | — | — |
| 2026-05-22 | Edward Clouston MacPherson | Director | MIXED | — | — |
| 2026-05-22 | Erez Aminov | CEO and Chairman | MIXED | — | — |
| 2026-04-24 | Erez Aminov | CEO and Chairman | J | +7,319,710 | +$10.03M |
| 2025-05-30 | Erez Aminov | CEO and Chairman | A | +2,400,000 deriv. | — |
| 2024-11-25 | Bay Shore Trust | 10%+ Owner | G | −100,000 deriv. | — |
| 2024-09-04 | Michelle Yanez | Chief Financial Officer | A | +200,000 deriv. | — |
| 2024-08-29 | Erez Aminov | CEO & Chairman | A | +1,960,170 deriv. | — |
| 2024-08-29 | Edward Clouston MacPherson | Director | A | +25,000 deriv. | — |
| 2024-08-29 | Michael Allen Jerman | Director | A | +25,000 deriv. | — |
| 2024-08-29 | Matthew Paul Del Giudice | Director | A | +25,000 deriv. | — |
| 2024-08-29 | Matthew Pratt Whalen | Director | A | +25,000 deriv. | — |
| 2024-02-15 | Bay Shore Trust | 10%+ Owner | Buy | +276,000 | +$1.93M |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Erez Aminov | CEO and Chairman | 7,319,710 | $7.31M |
| Bay Shore Trust | 10%+ Owner | 5,479,822 | $5.47M |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the TELO quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.